EUVIMEDEUVIMED entdecken
Open Access

Long-term clinical course of Mycobacterium avium complex pulmonary disease patients with treatment failure

Sungmin Zo, Junsu Choe, Dae Hun Kim, Su-Young Kim iD, Byung Woo Jhun iD

Antimicrobial Agents and Chemotherapy · 05.12.2024 · 68 (12)

DOI: 10.1128/aac.01055-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.12.2024. Verfasst von Sungmin Zo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medi…. Hauptthemen laut MEDLINE: Mycobacterium avium Complex, Mycobacterium avium-intracellulare Infection, Anti-Bacterial Agents, Treatment Failure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite guideline-based therapy, some patients with Mycobacterium avium complex pulmonary disease (MAC-PD) experience treatment failure. We analyzed the clinical courses of 271 patients with treatment-refractory MAC-PD who discontinued therapy after at least 12 months. Patients were categorized into two groups—the retreatment group, who resumed antibiotics due to clinical or radiological deterioration, and the stable group, who did not require antibiotics. Of the study patients, 138 (51%) were in the retreatment group, whereas 133 (49%) were in the stable group. In the multivariate analysis models, an elevated erythrocyte sedimentation rate (adjusted hazard ratio [aHR] =1.01), the presence of a cavity (aHR = 1.75), and the number of lobes affected by bronchiectasis (aHR = 1.21) were associated with the need for retreatment. Our data indicated that approximately 50% of the patients with refractory MAC-PD who discontinued antibiotics eventually required retreatment, which was influenced by the extent of lung destruction or inflammation. These findings can aid in determining treatment strategies for patients with refractory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium avium ComplexMycobacterium avium-intracellulare InfectionAnti-Bacterial AgentsTreatment FailureHumansMaleFemaleAgedMiddle AgedBronchiectasisRetrospective StudiesLung DiseasesBlood Sedimentation

Stichwörter der Autor:innen

Mycobacterium avium complexantibioticsnontuberculous mycobacteriaoutcome

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

ORCID-Profile: Su-Young Kim, Byung Woo Jhun

Förderung

  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Zo, S., Choe, J., Kim, D. H., Kim, S. Y., & Jhun, B. W. (2024). Long-term clinical course of Mycobacterium avium complex pulmonary disease patients with treatment failure. Antimicrobial Agents and Chemotherapy, 68(12). https://doi.org/10.1128/aac.01055-24

Vancouver

Zo S, Choe J, Kim DH, Kim SY, Jhun BW. Long-term clinical course of Mycobacterium avium complex pulmonary disease patients with treatment failure. Antimicrobial Agents and Chemotherapy. 2024;68(12). doi:10.1128/aac.01055-24

BibTeX
@article{Zo2024,
  author = {Zo, Sungmin and Choe, Junsu and Kim, Dae Hun and Kim, Su-Young and Jhun, Byung Woo},
  title = {Long-term clinical course of Mycobacterium avium complex pulmonary disease patients with treatment failure},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  volume = {68},
  number = {12},
  doi = {10.1128/aac.01055-24}
}
Kostenlos starten →